Lv21
166 积分 2023-05-22 加入
FRI-597 Impact of baseline hepatic steatosis on Peg-IFN-α therapy efficacy in chronic hepatitis B: a cohort study
4天前
已关闭
Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose
11天前
已完结
Alpha‐kinase 1 (ALPK1) agonist DF‐006 demonstrates potent efficacy in mouse and primary human hepatocyte (PHH) models of hepatitis B
11天前
已完结
Predictive models for functional cure in patients with CHB receiving PEG-IFN therapy based on HBsAg quantification through meta-analysis
1个月前
已完结
Discovery of Ervogastat (PF-06865571): A Potent and Selective Inhibitor of Diacylglycerol Acyltransferase 2 for the Treatment of Non-alcoholic Steatohepatitis
1个月前
已完结
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection
1个月前
已完结
A Major Step toward a Cure for Hepatitis B Infection
1个月前
已完结
LBP-031 AHB-137 monotherapy elicits high functional cure rates and sustained DNA suppression in treatment-naïve chronic hepatitis B participants: results from an ongoing phase II study
1个月前
已关闭
Preclinical and Clinical Pharmacokinetics of JNJ‐75220795, an siRNA Therapeutic Targeting PNPLA3, for Metabolic Dysfunction‐Associated Steatohepatitis
2个月前
已完结
Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD
2个月前
已完结
皖公网安备34019202002308
